Price Chart

Profile

Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
URL https://www.rayont.com
Investor Relations URL N/A
HQ State/Province California
Sector  
Industry  
Equity Style N/A
Next Earnings Release Jun. 06, 2024 (est.)
Last Earnings Release May. 15, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
URL https://www.rayont.com
Investor Relations URL N/A
HQ State/Province California
Sector  
Industry  
Equity Style N/A
Next Earnings Release Jun. 06, 2024 (est.)
Last Earnings Release May. 15, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A